Aida Pharmaceuticals (AIDA)

[PaperProphet]

The $7M is gone regardless of when it shows up. That was a lot of money and certainly the reason the market cap dropped. The market cap is down $15M from before that news became public so it may be a bit over done but there is extra risk in not having that cash. That $7M was very valuable. That would have sank most companies this size and it certainly hurt Aida.

As long as nothing happens to earnings, it should be a good stock. If phase three trials go well, they probably can find the money to build the plant. If not then they don't need to build the plant.